| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 75.92B | 75.75B | 73.83B | 78.40B | 78.00B | 71.47B |
| Gross Profit | 17.19B | 16.39B | 15.68B | 16.66B | 17.61B | 17.79B |
| EBITDA | 8.48B | 8.86B | 8.25B | 9.72B | 10.64B | 11.04B |
| Net Income | 4.80B | 4.85B | 4.49B | 6.28B | 6.81B | 6.36B |
Balance Sheet | ||||||
| Total Assets | 107.92B | 112.37B | 95.09B | 91.47B | 88.42B | 82.73B |
| Cash, Cash Equivalents and Short-Term Investments | 29.22B | 31.62B | 25.75B | 27.32B | 29.00B | 25.92B |
| Total Debt | 20.54B | 19.97B | 1.56B | 1.53B | 1.60B | 2.22B |
| Total Liabilities | 32.48B | 35.05B | 20.26B | 19.00B | 20.35B | 20.72B |
| Stockholders Equity | 75.43B | 77.32B | 74.84B | 72.47B | 68.08B | 62.01B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -7.29B | 3.57B | 3.79B | 4.50B | 2.36B |
| Operating Cash Flow | 0.00 | 4.89B | 7.39B | 6.56B | 7.74B | 9.10B |
| Investing Cash Flow | 0.00 | -12.46B | -3.85B | -5.83B | -2.36B | -5.69B |
| Financing Cash Flow | 0.00 | 13.73B | -2.82B | -3.12B | -1.43B | 2.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥26.68B | 9.01 | ― | 5.04% | -2.29% | -41.92% | |
67 Neutral | ¥396.94B | -16.12 | 7.93% | 2.32% | -2.26% | -10.86% | |
64 Neutral | ¥66.27B | 9.31 | ― | 3.31% | 3.24% | 26.38% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥121.21B | 45.55 | 6.98% | 3.13% | -2.13% | 37.10% | |
55 Neutral | ¥100.73B | 5.97 | ― | 4.87% | -4.44% | -47.54% |